Spermatogenesis Associated 9 (SPATA9) Peptide
SPATA9
Reactivité: Humain
Hôte: Synthetic
BP, WB
N° du produit ABIN984326
Aperçu rapide pour Spermatogenesis Associated 9 (SPATA9) Peptide (ABIN984326)
Antigène
SPATA9
(Spermatogenesis Associated 9 (SPATA9))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-SPATA9 antibody (Catalog #: ARP50024_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- SPATA9 (Spermatogenesis Associated 9 (SPATA9))
-
Sujet
-
SPATA9 may play a role in testicular development/spermatogenesis and may be an important factor in male infertility. Defects in expression of SPATA9 lead to Sertoli-cell-only syndrome.
Alias Symbols: FLJ35906, NYD-SP16
Protein Size: 254 -
Poids moléculaire
- 29 kDa
-
ID gène
- 83890
-
NCBI Accession
- NM_031952, NP_114158
-
UniProt
- Q9BWV2
Antigène
-
Vous êtes ici:
